Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amantadine and Transcranial Magnetic Stimulation for Treating Fatigue in Multiple Sclerosis
2021-004868-95Phase 4Active
- Sponsor
- Fundación para la Investigación Biomédica del Hospital Clínico San Carlos
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of amantadine in multiple sclerosis (MS) (4 arms), sponsored by Fundación para la Investigación Biomédica del Hospital Clínico San Carlos. Primary endpoint: Clinical response in fatigue. Started Dec 2021; status: active.
02
Drugs
amantadine
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2021-004868-95.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-004868-95.